LPL Financial’s Q32 Bio QTTB Stock Holding History

LPL Financial’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	+18,170	New	+$152K	﹤0.01%	5656

Other funds holding QTTB

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

LPL Financial's QTTB Position: Q2 2026 in Review

LPL Financial opened a new position in Q32 Bio (QTTB) in Q2 2026: 18,170 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #5656 among its holdings.

15 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

LPL Financial held 18,170 shares of Q32 Bio worth $231K as of Q2 2026.
Q32 Bio was a new LPL Financial position in Q2 2026.
Q32 Bio made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5656 holding.
15 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.